Preparing for the next pandemic.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
10 11 2023
Historique:
medline: 13 11 2023
pubmed: 9 11 2023
entrez: 9 11 2023
Statut: ppublish

Résumé

New lead drugs to treat COVID-19 are beginning to emerge.

Identifiants

pubmed: 37943911
doi: 10.1126/science.adk5868
doi:

Substances chimiques

Coronavirus Protease Inhibitors 0
Coronavirus 3C Proteases EC 3.4.22.28
3C-like proteinase, SARS-CoV-2 EC 3.4.22.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

649-650

Auteurs

Brian K Shoichet (BK)

Department of Pharmaceutical Chemistry, University of California San Francisco, San Franciso, CA, USA.

Charles S Craik (CS)

Department of Pharmaceutical Chemistry, University of California San Francisco, San Franciso, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH